Altered Serotonin 1A Binding in Major Depression: A [carbonyl-C-11]WAY100635 Positron Emission Tomography Study
暂无分享,去创建一个
Ramin V. Parsey | R. Todd Ogden | Victoria Arango | Maria A. Oquendo | Doreen M. Olvet | Ronald L. Van Heertum | R. V. Van Heertum | V. Arango | R. Parsey | R. Ogden | D. Olvet | J. Mann | M. Oquendo | J. Mann | N. Simpson | J. John Mann | Norman Simpson | Yung-yu Huang | M. Oquendo | R. Heertum | Yung-yu Huang
[1] E. Baca-García,et al. A computer algorithm for calculating the adequacy of antidepressant treatment in unipolar and bipolar depression. , 2003, Journal of Clinical Psychiatry.
[2] C. Katona,et al. Brain 5-HT1 binding sites in depressed suicides , 2005, Psychopharmacology.
[3] M. Åsberg,et al. 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? , 1976, Archives of general psychiatry.
[4] Marco Cecchi,et al. Serotonin Clearance In Vivo Is Altered to a Greater Extent by Antidepressant-Induced Downregulation of the Serotonin Transporter than by Acute Blockade of this Transporter , 2002, The Journal of Neuroscience.
[5] J. Talairach,et al. Co-Planar Stereotaxic Atlas of the Human Brain: 3-Dimensional Proportional System: An Approach to Cerebral Imaging , 1988 .
[6] Stephen M. Smith,et al. A global optimisation method for robust affine registration of brain images , 2001, Medical Image Anal..
[7] C. Halldin,et al. Localization of 5-HT1A receptors in the living human brain using [carbonyl-11C]WAY-100635: PET with anatomic standardization technique. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[8] P A Sargent,et al. Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. , 2000, Archives of general psychiatry.
[9] M Slifstein,et al. Validation and Reproducibility of Measurement of 5-HT1A Receptor Parameters with [carbonyl-11C]WAY-100635 in Humans: Comparison of Arterial and Reference Tissue Input Functions , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[10] Alexander Hammers,et al. Automatic segmentation of the brain and intracranial cerebrospinal fluid in T1‐weighted volume MRI scans of the head, and its application to serial cerebral and intracranial volumetry , 2003, Magnetic resonance in medicine.
[11] C. Montigny,et al. Autoradiographic quantification of serotonin1A receptors in rat brain following antidepressant drug treatment , 1989, Synapse.
[12] P. Cowen,et al. Blunted growth hormone and prolactin responses to L-tryptophan in depression; a state-dependent abnormality. , 1991, Journal of affective disorders.
[13] H. Ågren. Symptom patterns in unipolar and bipolar depression correlating with monoamine metabolites in the cerebrospinal fluid: II. Suicide , 1980, Psychiatry Research.
[14] Anat Biegon,et al. Autoradiographic analysis of serotonin 5-HT1A receptor binding in the human brain postmortem: effects of age and alcohol , 1991, Brain Research.
[15] N. Alpert,et al. Comparison of 4 methods for quantification of dopamine transporters by SPECT with [123I]IACFT. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[16] G. Rajkowska,et al. Increase in Serotonin-1A Autoreceptors in the Midbrain of Suicide Victims with Major Depression—Postmortem Evidence for Decreased Serotonin Activity , 1998, The Journal of Neuroscience.
[17] K. Hole,et al. Desipramine, administered chronically, influences 5-hydroxytryptamine1A-receptors, as measured by behavioural tests and receptor binding in rats , 1992, Neuropharmacology.
[18] M. Hamilton. A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.
[19] S. Svebak,et al. Clonazepam and imipramine in the treatment of panic attacks: a double-blind comparison of efficacy and side effects. , 1990, The Journal of clinical psychiatry.
[20] A. Lammertsma,et al. Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.
[21] Allan L. Reiss,et al. Reliability and validity of MRI measurement of the amygdala and hippocampus in children with fragile X syndrome , 1997, Psychiatry Research: Neuroimaging.
[22] J. John Mann,et al. Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims , 1995, Brain Research.
[23] Victoria Arango,et al. Regional Heterogeneity of 5-HT1A Receptors in Human Cerebellum as Assessed by Positron Emission Tomography , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[24] J. Kleinman,et al. Serotonin Uptake Sites and Serotonin Receptors Are Altered in the Limbic System of Schizophrenics , 1993, Neuropsychopharmacology.
[25] P A Sargent,et al. Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635 , 2004, Molecular Psychiatry.
[26] M. Åsberg,et al. Monoamine metabolites in CSF and suicidal behavior. , 1981, Archives of general psychiatry.
[27] S. Gershon,et al. Parachlorophenylalanine reversal of tranylcypromine effects in depressed patients. , 1976, Archives of general psychiatry.
[28] Peter Herscovitch,et al. Reduced Serotonin Type 1A Receptor Binding in Panic Disorder , 2004, The Journal of Neuroscience.
[29] J. Fleiss,et al. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. , 1976, Archives of general psychiatry.
[30] T. Segawa,et al. Chronic effects of imipramine and lithium on postsynaptic 5-HT1A and 5-HT1B sites and on presynaptic 5-HT3 sites in rat brain. , 1988, Japanese journal of pharmacology.
[31] M Slifstein,et al. Derivation of [(11)C]WAY-100635 binding parameters with reference tissue models: effect of violations of model assumptions. , 2000, Nuclear medicine and biology.
[32] D. Kupfer,et al. Pet imaging of serotonin 1A receptor binding in depression , 1999, Biological Psychiatry.
[33] K. Vinod,et al. Modulation of 5-HT1A receptor mediated response by fluoxetine in rat brain , 2000, Journal of Neural Transmission.
[34] Victoria Arango,et al. Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT1A receptor binding potential measured by PET using [C-11]WAY-100635 , 2002, Brain Research.
[35] G. Aghajanian,et al. Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. , 1990, Archives of general psychiatry.
[36] A. Beck,et al. An inventory for measuring depression. , 1961, Archives of general psychiatry.
[37] J. Nelson. A review of the efficacy of serotonergic and noradrenergic reuptake inhibitors for treatment of major depression , 1999, Biological Psychiatry.
[38] Gustavo Turecki,et al. Impaired Repression at a 5-Hydroxytryptamine 1A Receptor Gene Polymorphism Associated with Major Depression and Suicide , 2003, The Journal of Neuroscience.
[39] C. de Montigny,et al. A role for the serotonin system in the mechanism of action of antidepressant treatments: preclinical evidence. , 1990, The Journal of clinical psychiatry.
[40] D. Comings,et al. A common C-1018G polymorphism in the human 5-HT1A receptor gene. , 1999, Psychiatric genetics.
[41] C. Katona,et al. 5-HT1A receptor binding sites in post-mortem brain samples from depressed suicides and controls. , 1997, Journal of affective disorders.
[42] D. Charney,et al. Serotonergic function in depression. Prolactin response to intravenous tryptophan in depressed patients and healthy subjects. , 1984, Archives of general psychiatry.
[43] L. Siever,et al. Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior. , 1989, Archives of general psychiatry.
[44] J. Marcusson,et al. Brain 5-HT1A, 5-HT1D, and 5-HT2 Receptors in suicide victims , 1994, Biological Psychiatry.
[45] V. Arango,et al. Integration of Neurobiology and Psychopathology in a Unified Model of Suicidal Behavior , 1992, Journal of clinical psychopharmacology.
[46] R. Salomon,et al. Serotonin and the neurobiology of depression. Effects of tryptophan depletion in drug-free depressed patients. , 1994, Archives of general psychiatry.
[47] Victoria Arango,et al. Serotonin 1A Receptors, Serotonin Transporter Binding and Serotonin Transporter mRNA Expression in the Brainstem of Depressed Suicide Victims , 2001, Neuropsychopharmacology.
[48] P A Sargent,et al. Exquisite delineation of 5-HT1A receptors in human brain with PET and [carbonyl-11 C]WAY-100635. , 1996, European journal of pharmacology.
[49] M. Åsberg,et al. Therapeutic effects of serotonin uptake inhibitors in depression. , 1986, The Journal of clinical psychiatry.
[50] H. Sackeim,et al. The Impact of Medication Resistance and Continuation Pharmacotherapy on Relapse following Response to Electroconvulsive Therapy in Major Depression , 1990, Journal of clinical psychopharmacology.
[51] W C Eckelman,et al. Quantification of Amphetamine-Induced Changes in [11C]Raclopride Binding with Continuous Infusion , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[52] I A Cliffe,et al. A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635. , 1995, European journal of pharmacology.
[53] M. Hamon,et al. The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes. , 1995, European journal of pharmacology.
[54] P B Hoffer,et al. Compartmental modeling of iodine-123-iodobenzofuran binding to dopamine D2 receptors in healthy subjects. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[55] H. Duvernoy. The Human Brain , 1999, Springer Vienna.
[56] T. Dinan,et al. Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function. , 1991, The American journal of psychiatry.
[57] Á. Díaz,et al. Chronic fluoxetine induces opposite changes in G protein coupling at pre and postsynaptic 5-HT1A receptors in rat brain , 2003, Neuropharmacology.
[58] T Sandor,et al. An interactive procedure for extracting features of the brain from magnetic resonance images: The lobes , 1997, Human brain mapping.
[59] M. Mintun,et al. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography , 1984, Annals of neurology.
[60] G. Mengod,et al. Desensitization of 5-HT1A Autoreceptors by a Low Chronic Fluoxetine Dose Effect of the Concurrent Administration of WAY-100635 , 2001, Neuropsychopharmacology.
[61] D. Murphy,et al. Plasma prolactin changes following fenfluramine in depressed patients compared to controls: an evaluation of central serotonergic responsivity in depression. , 1984, Life sciences.
[62] E. Cabanis,et al. The Human Brain: Surface, Three-Dimensional Sectional Anatomy and Mri , 1991 .
[63] A. Neumeister,et al. Implications of genetic research on the role of the serotonin in depression: emphasis on the serotonin type 1A receptor and the serotonin transporter , 2004, Psychopharmacology.
[64] Claudette Boni,et al. Differential adaptation of brain 5-HT1A and 5-HT1B receptors and 5-HT transporter in rats treated chronically with fluoxetine , 2000, Neuropharmacology.
[65] B. McEwen,et al. Stress and antidepressant effects on hippocampal and cortical 5-HT1A and 5-HT2 receptors and transport sites for serotonin , 1993, Brain Research.
[66] H. Meltzer,et al. Serotonin Receptors in Suicide Victims with Major Depression , 1997, Neuropsychopharmacology.
[67] Roger N. Gunn,et al. Tracer Kinetic Modeling of the 5-HT1AReceptor Ligand [carbonyl-11C]WAY-100635 for PET , 1998, NeuroImage.
[68] S. Watson,et al. Regulation of Serotonin1A, Glucocorticoid, and Mineralocorticoid Receptor in Rat and Human Hippocampus: Implications for the Neurobiology of Depression , 1998, Biological Psychiatry.